Kuros Biosciences AG logo

Kuros Biosciences AG

SIX:KURN.SW

Overview | Financials
Company Name Kuros Biosciences AG
Symbol KURN.SW
Currency CHF
Price 11.4
Market Cap 422,946,338
Dividend Yield 0%
52-week-range 1.255 - 12.96
Industry Biotechnology
Sector Healthcare
CEO Dr. Joost D. de Bruijn B.Sc. Ph.D., Ph.D.
Website https://www.kuros.ch

An error occurred while fetching data.

About Kuros Biosciences AG

Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development of biopharmaceutical products for tissue repair and bone regeneration in the United States, the European Union, and internationally. It operates through Medical Devices, Pharmaceuticals, and Legacy Portfolio. The company's orthobiologics pipeline products include MagnetOs Granules and MagnetOs Putty

Related Stocks

Newron Pharmaceuticals S.p.A. logo

Newron Pharmaceuticals S.p.A.

NWRN.SW

10.72 CHF

Santhera Pharmaceuticals Holding AG logo

Santhera Pharmaceuticals Holding AG

SANN.SW

9.5 CHF

Evolva Holding SA logo

Evolva Holding SA

EVE.SW

0.97 CHF

Molecular Partners AG logo

Molecular Partners AG

MOLN.SW

9 CHF

Relief Therapeutics Holding AG logo

Relief Therapeutics Holding AG

RLF.SW

1.11 CHF

Financials

Numbers are in millions USD

Numbers are in millions USD